SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 527.29 |
| Enterprise Value ($M) | 557.63 |
| Book Value ($M) | 302.97 |
| Book Value / Share | 2.23 |
| Price / Book | 1.74 |
| NCAV ($M) | -74.33 |
| NCAV / Share | -0.55 |
| Price / NCAV | -7.09 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.08 |
| Return on Assets (ROA) | -0.06 |
| Return on Equity (ROE) | -0.10 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.27 |
| Current Ratio | 1.27 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 156.96 |
| Assets | 534.26 |
| Liabilities | 231.29 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,259 | 12,048 | 27.05 | |
| 574 | 7,007 | 8.19 | |
| 3,593 | 23,140 | 15.53 | |
| 1,866 | 44,806 | 4.16 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IMUX – Immunic, Inc. | IMVT – Immunovant, Inc. |
| INDV – Indivior PLC | INSM – Insmed Incorporated |
| INVA – Innoviva, Inc. |
Financial data and stock pages provided by
Fintel.io